[Home oxygen therapy]. / Oxygénothérapie à domicile.

Only severe hypoxemia at rest in COPD patients has strong recommendations for long-term oxygen therapy. It is accepted that oxygen should be prescribed if PaO2 is ≤ 7,3 kPa (55 mmHg), or if PaO2 is ≤ 8 kPa (60 mmHg) in the presence of signs of pulmonary hypertension or a hematocrit ≥ 55 %. In Switzerland, prescription is governed by the LiMA (Liste des moyens et appareils) and the patient can obtain supplies from a health care provider or directly from the provider. The most suitable device taking patient's oxygen needs and mobility into account must be chosen. O2 prescription entails risks for the patient that must be known to the prescriber. This article presents the different aspects of long-term home oxygen therapy.

Seule l'hypoxémie sévère au repos chez le patient BPCO possède de solides recommandations pour la prescription d'oxygène au long cours. L'hypoxémie sévère est définie par une pression partielle en oxygène dans le sang artériel (PaO2) ≤ 7,3 kPa (55 mmHg) ou une PaO2 ≤ à 8 kPa (60 mmHg) en présence de signes d'hypertension pulmonaire ou d'un taux d'hématocrite ≥ 55 %. En Suisse, sa prescription est régie par la liste des moyens et appareils (LiMA) et le patient peut s'approvisionner auprès d'un prestataire de soins ou directement auprès du fournisseur. Le dispositif le mieux adapté à chaque patient tenant compte de son besoin en oxygène et de sa mobilité doit être choisi. Sa prescription entraîne des risques pour le patient, qui doivent être connus du prescripteur. Cet article expose les différents aspects de l'oxygénothérapie au long cours à domicile.

Long-Term Mechanical Ventilation: Recommendations of the Swiss Society of Pulmonology.

Long-term mechanical ventilation is a well-established treatment for chronic hypercapnic respiratory failure (CHRF). It is aimed at improving CHRF-related symptoms, health-related quality of life, survival, and decreasing hospital admissions. In Switzerland, long-term mechanical ventilation has been increasingly used since the 1980s in hospital and home care settings. Over the years, its application has considerably expanded with accumulating evidence of beneficial effects in a broad range of conditions associated with CHRF. Most frequent indications for long-term mechanical ventilation are chronic obstructive pulmonary disease, obesity hypoventilation syndrome, neuromuscular and chest wall diseases. In the current consensus document, the Special Interest Group of the Swiss Society of Pulmonology reviews the most recent scientific literature on long-term mechanical ventilation and provides recommendations adapted to the particular setting of the Swiss healthcare system with a focus on the practice of non-invasive and invasive home ventilation in adults.